MedPath

Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients

Not Applicable
Completed
Conditions
Polypharmacy
Adverse Drug Reaction
Interventions
Other: Educational intervention
Registration Number
NCT01732302
Lead Sponsor
Karolinska Institutet
Brief Summary

The purpose of this study is to determine whether an educational intervention given towards health care providers working in primary health care centers can reduce inappropriate prescribing in the elderly patient and thus reduce number and length of drug-related hospitalizations as well as number of emergency department visits in this patient group.

Detailed Description

Inappropriate medication in the elderly patient leads to substantial morbidity, possibly causing up to 20% of hospitalizations in this patient group (1). To improve prescribing and thus reduce undesired drug effects is a great challenge for doctors and nurses in primary health care.

Performance of drug utilization reviews is recommended in order to reduce the negative impact of inappropriate prescribing in the elderly. However, scientific evidence on their efficacy is lacking, especially regarding patient-related health outcomes (2,3). Most studies are carried out in inpatient care, making it difficult to draw conclusions regarding primary health care (2). Moreover, studies in this scientific field diverge regarding the content and structure of drug utilization reviews, which implies that comparison between studies becomes challenging, if not impossible.

This trial aims at educating health care providers in how to perform drug utilization reviews, and to help them implement theory into practice.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
69
Inclusion Criteria
  • primary health care center in Stockholm County
  • authorized by Stockholm County Council since at least 3 years
  • at least 5% of patients attributed to primary health care center are 65 years and older
  • primary health care center takes care of at least 10 home care patients
Exclusion Criteria
  • less than 3000 patients listed in primary health care center
  • primary health care centers where researchers carrying out the present study work

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Educational interventionEducational interventionPrimary health care centers (PHCC) in the intervention group will be visited twice by a pharmacist within a period of three months. At the first visit, an educational intervention will focus on two properties: on the one hand, feed-back of actual patient data of the PHCC illustrating the primary-health-care-specific characteristics of inappropriate prescribing in the elderly patient will be given. Education of relevant subjects will be given in relation to detected problems. On the other hand, a clinical routine regarding the performance of drug utilization reviews will be developed in cooperation with the health care providers. At the second visit 3 months later, the developed concept will be critically reviewed and eventually developed further.
Primary Outcome Measures
NameTimeMethod
Composite outcome: Unplanned hospitalisation or emergency department visit9 months
Secondary Outcome Measures
NameTimeMethod
Emergency department visit9 months
Number of drug utilization reviews9 months
Number of patients with polypharmacy9 months

polypharmacy: 5-9 drugs/patient excessive polypharmacy: 10 and more drugs/patient

Inappropriate drug use according to national guidelines9 months

see link

Unplanned hospitalisation9 months
Length of hospital stay9 months
All cause mortality9 months
Number of patients with contraindicated drugs regarding renal function9 months
Number of drugs with inappropriate drug dose regarding renal function9 months
Number of drug interactions9 months

Trial Locations

Locations (1)

Centre for Family Medicine, Dept of Neurobiology, Care sciences and Society, Karolinska Institutet

🇸🇪

Huddinge, Sweden

© Copyright 2025. All Rights Reserved by MedPath